Two experts from Cerevance discussed data from the company’s posters recently presented at AAIC 2025, which highlighted potential therapeutic targets for Alzheimer disease. [WATCH TIME: 5 minutes]
Mark Carlton, PhD
Advertisement
Chief scientific officer at Cerevance.
Articles by Mark Carlton, PhD
Advertisement
Latest Updated Articles
Advancing Neurodegenerative Disease Research With Innovative Targets and Platforms: Xiao Xu, PhD; Mark Carlton, PhDPublished: August 7th 2025 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Clene to Submit Application for CNM-Au8 as Potential ALS Treatment
2
Overview and Design of the OCEANIC-STROKE Trial
3
Multidisciplinary Care Paths That Improve Neurosarcoidosis Management
4
This Week on NeurologyLive® — November 17, 2025
5
